flibanserin
‘Female Viagra’ goes on sale in the US
October 20, 2015Addyi, HSDD, Sprout, female viagra, flibanserin, hypoactive sexual desire disorder
The pill dubbed the female version of Viagra – Sprout Pharmaceuticals’ Addyi – has gone on sale in the US. …
Valeant confirms $1bn deal for ‘female viagra’ creator Sprout
August 20, 2015Manufacturing and Production, Sales and Marketing Addyi, Sprout, Sprout Pharma, Sprout Pharmaceuticals, Valeant, flibanserin
Canada’s Valeant Pharmaceuticals has confirmed it will pay $1 billion to acquire Sprout Pharmaceuticals, the company behind the female libido …
FDA approves ‘female viagra’
August 19, 2015Research and Development, Sales and Marketing Addyi, FDA, HSDD, Sprout, Sprout Pharmaceuticals, flibanserin, hypoactive sexual desire disorder
The FDA has approved Sprout Pharmaceuticals’ Addyi, a controversial libido-enhancing drug for women that has been dubbed the ‘female viagra’. …
FDA to assess female libido drug
June 4, 2015Sales and Marketing FDA, Sprout Pharmaceutical, flibanserin, libido
The FDA is inching closer to a historic approval of a drug in the US commonly dubbed ‘Viagra for women’. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
